- $1.32bn
- $1.34bn
- $31.82m
Annual balance sheet for Enovix, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | 2025 December 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 385 | 307 | 323 | 273 | 512 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 2.42 | 0.17 | 4.57 | 8.43 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 398 | 323 | 330 | 295 | 542 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 83.3 | 182 | 110 | 181 | 182 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 483 | 564 | 441 | 527 | 879 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.6 | 61 | 23 | 53.7 | 65 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 156 | 306 | 84.2 | 280 | 608 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 326 | 258 | 356 | 247 | 271 |
| Total Liabilities & Shareholders' Equity | 483 | 564 | 441 | 527 | 879 |
| Total Common Shares Outstanding |